Study: Blocking IL1α protein decreases severity of inflammation in Crohn's disease

Investigators at the Case Western Reserve University School of Medicine discovered that blocking interleukin-1α (IL1α), a protein that controls inflammation in the gut, markedly decreases the severity of intestinal inflammation in a mouse model of Crohn’s disease (CD).

Source link

Related posts

New drug cocktails make targeted cancer therapies more efficient with less side effects


Colectomies for UC Decline in the Era of Biologics


H. pylori resistance to clarithromycin doubles in Europe


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy